Global Pharmaceutical Manufacturing Market 2022-2028

December 2022 | 75 pages | ID: G97E7E6B261FEN
Gen Consulting Company

Abstracts

The global pharmaceutical manufacturing market is projected to rise by USD 421.0 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 11 percent during the forecast period.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global pharmaceutical manufacturing market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the pharmaceutical manufacturing industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug development type, formulation, administration route, prescription, therapy area, age type, and region. The global market for pharmaceutical manufacturing can be segmented by drug development type: outsource, in-house. Among these, the outsource segment was accounted for the highest revenue generator in 2021. Pharmaceutical manufacturing market is further segmented by formulation: tablet, capsule, injectable, spray, suspension, powder, others. The tablet segment is estimated to account for the largest share of the global pharmaceutical manufacturing market. Based on administration route, the pharmaceutical manufacturing market is segmented into: oral, topical, parenteral, inhalation, others. The oral segment held the largest share of the global pharmaceutical manufacturing market in 2021 and is anticipated to hold its share during the forecast period. On the basis of prescription, the pharmaceutical manufacturing market also can be divided into: prescription medicines, over-the-counter (OTC) medicines. In 2021, the OTC medicines segment made up the largest share of revenue generated by the pharmaceutical manufacturing market. Pharmaceutical manufacturing market by therapy area is categorized into: cardiovascular diseases, pain, cancer, respiratory diseases, others. The pharmaceutical manufacturing market by age type can be segmented into: children and adolescent, adult, geriatric. Based on region, the pharmaceutical manufacturing market is further categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation

By drug development type: outsource, in-house

By formulation: tablet, capsule, injectable, spray, suspension, powder, others

By administration route: oral, topical, parenteral, inhalation, others

By prescription: prescription medicines, over-the-counter (OTC) medicines

By therapy area: cardiovascular diseases, pain, cancer, respiratory diseases, others

By age type: children and adolescent, adult, geriatric

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report has also analysed the competitive landscape of the global pharmaceutical manufacturing market with some of the key players being AstraZeneca plc, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Johnson & Johnson, Jubilant Life Sciences Limited, Lonza Group AG, Merck & Co., Inc., Pfizer, Inc., Roche Holding AG, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., WuXi AppTec Co., Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global pharmaceutical manufacturing market.
• To classify and forecast the global pharmaceutical manufacturing market based on drug development type, formulation, administration route, prescription, therapy area, age type, region.
• To identify drivers and challenges for the global pharmaceutical manufacturing market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pharmaceutical manufacturing market.
• To identify and analyze the profile of leading players operating in the global pharmaceutical manufacturing market.

Why Choose This Report

• Gain a reliable outlook of the global pharmaceutical manufacturing market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY DRUG DEVELOPMENT TYPE

Outsource
In-house

PART 6. MARKET BREAKDOWN BY FORMULATION

Tablet
Capsule
Injectable
Spray
Suspension
Powder
Others

PART 7. MARKET BREAKDOWN BY ADMINISTRATION ROUTE

Oral
Topical
Parenteral
Inhalation
Others

PART 8. MARKET BREAKDOWN BY PRESCRIPTION

Prescription medicines
Over-the-counter (OTC) medicines

PART 9. MARKET BREAKDOWN BY THERAPY AREA

Cardiovascular diseases
Pain
Cancer
Respiratory diseases
Others

PART 10. MARKET BREAKDOWN BY AGE TYPE

Children and adolescent
Adult
Geriatric

PART 11. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 12. KEY COMPANIES

AstraZeneca plc
Fujifilm Diosynth Biotechnologies U.S.A., Inc.
Johnson & Johnson
Jubilant Life Sciences Limited
Lonza Group AG
Merck & Co., Inc.
Pfizer, Inc.
Roche Holding AG
Samsung Biologics Co., Ltd.
Thermo Fisher Scientific, Inc.
WuXi AppTec Co., Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER